Suppr超能文献

一种人类肠道细菌通过改变邻近细菌的蛋白质折叠能力来对抗它们。

A human gut bacterium antagonizes neighboring bacteria by altering their protein-folding ability.

作者信息

Lim Bentley, Xu Jinghua, Wierzbicki Igor H, Gonzalez Carlos G, Chen Zhe, Gonzalez David J, Gao Xiang, Goodman Andrew L

机构信息

Department of Microbial Pathogenesis and Microbial Sciences Institute, Yale University School of Medicine, New Haven, CT 06536, USA.

State Key Laboratory of Microbial Technology, Shandong University, Qingdao 266237, China.

出版信息

Cell Host Microbe. 2025 Feb 12;33(2):200-217.e24. doi: 10.1016/j.chom.2025.01.008. Epub 2025 Feb 4.

Abstract

Antagonistic interactions play a key role in determining microbial community dynamics. Here, we report that one of the most widespread contact-dependent effectors in human gut microbiomes, Bte1, directly targets the PpiD-YfgM periplasmic chaperone complex in related microbes. Structural, biochemical, and genetic characterization of this interaction reveals that Bte1 reverses the activity of the chaperone complex, promoting substrate aggregation and toxicity. Using Bacteroides, we show that Bte1 is active in the mammalian gut, conferring a fitness advantage to expressing strains. Recipient cells targeted by Bte1 exhibit sensitivity to membrane-compromising conditions, and human gut microbes can use this effector to exploit pathogen-induced inflammation in the gut. Further, Bte1 allelic variation in gut metagenomes provides evidence for an arms race between Bte1-encoding and immunity-encoding strains in humans. Together, these studies demonstrate that human gut microbes alter the protein-folding capacity of neighboring cells and suggest strategies for manipulating community dynamics.

摘要

拮抗相互作用在决定微生物群落动态中起着关键作用。在此,我们报告称,人类肠道微生物群中最广泛存在的接触依赖性效应蛋白之一Bte1,直接靶向相关微生物中的PpiD-YfgM周质伴侣蛋白复合物。这种相互作用的结构、生化和遗传学特征表明,Bte1会逆转伴侣蛋白复合物的活性,促进底物聚集和毒性。利用拟杆菌,我们表明Bte1在哺乳动物肠道中具有活性,赋予表达菌株适应性优势。被Bte1靶向的受体细胞对膜损伤条件敏感,并且人类肠道微生物可以利用这种效应蛋白来利用肠道中病原体诱导的炎症。此外,肠道宏基因组中的Bte1等位基因变异为人类中编码Bte1的菌株和编码免疫的菌株之间的军备竞赛提供了证据。总之,这些研究表明人类肠道微生物会改变邻近细胞的蛋白质折叠能力,并提出了操纵群落动态的策略。

相似文献

1
A human gut bacterium antagonizes neighboring bacteria by altering their protein-folding ability.
Cell Host Microbe. 2025 Feb 12;33(2):200-217.e24. doi: 10.1016/j.chom.2025.01.008. Epub 2025 Feb 4.
4
Genetic Manipulation of Wild Human Gut .
J Bacteriol. 2020 Jan 15;202(3). doi: 10.1128/JB.00544-19.
5
The Landscape of Type VI Secretion across Human Gut Microbiomes Reveals Its Role in Community Composition.
Cell Host Microbe. 2017 Sep 13;22(3):411-419.e4. doi: 10.1016/j.chom.2017.08.010.
7
Acquisition of MACPF domain-encoding genes is the main contributor to LPS glycan diversity in gut Bacteroides species.
ISME J. 2018 Dec;12(12):2919-2928. doi: 10.1038/s41396-018-0244-4. Epub 2018 Jul 31.
8
Streamlined Genetic Manipulation of Diverse and Isolates from the Human Gut Microbiota.
mBio. 2019 Aug 13;10(4):e01762-19. doi: 10.1128/mBio.01762-19.
10
Surface glycan-binding proteins are essential for cereal beta-glucan utilization by the human gut symbiont Bacteroides ovatus.
Cell Mol Life Sci. 2019 Nov;76(21):4319-4340. doi: 10.1007/s00018-019-03115-3. Epub 2019 May 6.

引用本文的文献

本文引用的文献

1
Balancing Act of the Intestinal Antimicrobial Proteins on Gut Microbiota and Health.
J Microbiol. 2024 Mar;62(3):167-179. doi: 10.1007/s12275-024-00122-3. Epub 2024 Apr 17.
2
Chaperones-A New Class of Potential Therapeutic Targets in Alzheimer's Disease.
Int J Mol Sci. 2024 Mar 17;25(6):3401. doi: 10.3390/ijms25063401.
3
Bacteroides fragilis ubiquitin homologue drives intraspecies bacterial competition in the gut microbiome.
Nat Microbiol. 2024 Jan;9(1):70-84. doi: 10.1038/s41564-023-01541-5. Epub 2023 Dec 11.
5
Infection leaves a genetic and functional mark on the gut population of a commensal bacterium.
Cell Host Microbe. 2023 May 10;31(5):811-826.e6. doi: 10.1016/j.chom.2023.04.005. Epub 2023 Apr 28.
6
The chaperone system in cancer therapies: Hsp90.
J Mol Histol. 2023 Apr;54(2):105-118. doi: 10.1007/s10735-023-10119-8. Epub 2023 Mar 18.
8
The conserved domain database in 2023.
Nucleic Acids Res. 2023 Jan 6;51(D1):D384-D388. doi: 10.1093/nar/gkac1096.
10
HSP90 inhibitors and cancer: Prospects for use in targeted therapies (Review).
Oncol Rep. 2023 Jan;49(1). doi: 10.3892/or.2022.8443. Epub 2022 Nov 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验